These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17630612)

  • 1. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ; Rogol AD
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
    Rosenbloom AL
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mecasermin: new drug. Insufficient improvement in statural growth.
    Prescrire Int; 2009 Jun; 18(101):111-3. PubMed ID: 19637420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R; Camacho-Hübner C; Attie KM; Savage MO
    Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB; Wollmann HA; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract]   [Full Text] [Related]  

  • 10. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
    Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy for short children born small for gestational age.
    Chatelain P; Carrascosa A; Bona G; Ferrandez-Longas A; Sippell W
    Horm Res; 2007; 68(6):300-9. PubMed ID: 17823537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
    Backeljauw P
    Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
    [No Abstract]   [Full Text] [Related]  

  • 16. Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.
    Bang P
    Horm Res Paediatr; 2011; 76 Suppl 3():24-6. PubMed ID: 21912155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-resistant syndromes: long-term follow-up.
    Chernausek SD
    Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone deficiency in children: an approach to a child with short stature.
    Chowdhury S; Chatterjee P
    J Indian Med Assoc; 2004 Aug; 102(8):446, 449-52. PubMed ID: 15719807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SomatoKine: is there a use in treating growth disorders?
    Kemp SF; Thrailkill KM
    Curr Opin Investig Drugs; 2005 Apr; 6(4):373-7. PubMed ID: 15898344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.